Human CYP2C9 Metabolism of Organophosphorus Pesticides and Nerve Agent Surrogates
Journal of Xenobiotics · 19.12.2025 · 16 (1) · 1
DOI: 10.3390/jox16010001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Xenobiotics, online erschienen am 19.12.2025. Verfasst von Pratik Shriwas und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Defense Threat Reduction Agency, Defense Threat Reduction Agency, an affiliate of the Department of Defense.
Abstract (Originalsprache)
Of the Cytochrome P450 enzymes, the CYP2C9 variant is very important in the metabolism of several human drugs, acting as a natural bioscavenger. Previously, CYP2C9 was shown to convert the thion (P=S) to the oxon (P=O) form for some organophosphorus (OP) pesticides, such as dimethoate, diazinon, and parathion. In this study, we tested the ability of CYP2C9 to degrade other OP compounds. We investigated the metabolism of OP compounds by CYP2C9 using LC-MS/MS as well as time-dependent inhibition using the previously developed pFluor50 fluorogenic assay. We found that CYP2C9 metabolizes thions preferentially over oxons, and that many OP compounds inhibit CYP2C9 activity in a time-dependent manner. Additionally, we performed molecular docking based on the crystal structure (1OG5) of the CYP2C9 receptor. We observed a positive, though moderate, correlation between the calculated binding energy and the CYP2C9 metabolism of various OP compounds (R = 0.59). These in vitro data, combined with further analysis and additional OP derivatives, could potentially be used to develop artificial intelligence (AI)/machine learning (ML) models to predict the metabolism of specific OP compounds by CYP2C9. This type of approach could be particularly relevant for the prediction of the metabolism of current and emerging chemical warfare agents.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Medical Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA.
- Department of Chemistry and Biochemistry, College of Arts and Sciences, The Ohio State University, Columbus, OH 43210, USA.
- Collaborations Pharmaceuticals, Raleigh, NC 27606, USA.
ORCID-Profile: Pratik Shriwas, Abigail M Noonchester, Thomas R Lane, Christopher M Hadad, Sean Ekins, Craig A McElroy
Förderung
- Defense Threat Reduction Agency
- Defense Threat Reduction Agency, an affiliate of the Department of Defense
Zitieren
APA
Shriwas, P., Noonchester, A. M., Revnew, A., Lane, T. R., Hadad, C. M., Ekins, S., & McElroy, C. A. (2025). Human CYP2C9 Metabolism of Organophosphorus Pesticides and Nerve Agent Surrogates. Journal of Xenobiotics, 16(1), 1. https://doi.org/10.3390/jox16010001
Vancouver
Shriwas P, Noonchester AM, Revnew A, Lane TR, Hadad CM, Ekins S, et al. Human CYP2C9 Metabolism of Organophosphorus Pesticides and Nerve Agent Surrogates. Journal of Xenobiotics. 2025;16(1):1. doi:10.3390/jox16010001
BibTeX
@article{Shriwas2025,
author = {Shriwas, Pratik and Noonchester, Abigail M and Revnew, Andre and Lane, Thomas R and Hadad, Christopher M and Ekins, Sean and McElroy, Craig A},
title = {Human CYP2C9 Metabolism of Organophosphorus Pesticides and Nerve Agent Surrogates},
journal = {Journal of Xenobiotics},
year = {2025},
volume = {16},
number = {1},
pages = {1},
doi = {10.3390/jox16010001}
}
EUVIMED